Latest filing published 04 Jun 2015 for Interpace Biosciences, INC., €53k.
Insider track record
No signal scores available.
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -97.4%Entry 2.47 · Close at T+365 0.06
- +7.0%Entry 2.58 · Close at T+365 2.76
- -44.8%Entry US$32.55 · Close at T+365 US$17.98
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gerald P. Belle: trading record in brief
Gerald P. Belle discloses dealings in 3 companies, chiefly Interpace Biosciences, Inc., Myriad Pharmaceuticals, Inc. and Myriad Genetics Inc. Between 7 May 2009 and 3 June 2015, the trades on record add up to 18 filings.
Purchases make up the whole of the open-market record (10 purchases, €345k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 8 share grants.
In size, the median ticket on the buying side is €26k. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 80% of cases; the median change was +3.6%. This is a record of the past, not a forecast.
On 11 June 2015 came the latest disclosure, a share grant for €53k in Interpace Biosciences, Inc. The last insider purchase was made public on 7 November 2014, 4,384 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gerald P. Belle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 45,455 shares@ US$1.32Common StockSEC:0001140361-15-023273:0
- 57,300 shares@ US$1.71Common StockSEC:0001140361-14-040599:0Canonical exit: 3 Feb 2015 (T+90)
- 13,274 shares@ US$4.52Common StockSEC:0001140361-14-024621:0
- 7,400 shares@ US$5.14Common stockSEC:0001140361-13-043456:0Canonical exit: 13 Feb 2014 (T+90)
- 13,000 shares@ US$5.25Common StockSEC:0001140361-13-043456:1Canonical exit: 16 Feb 2014 (T+90)
- 13,423 shares@ US$4.47Common StockSEC:0001140361-13-024331:0
- 7,435 shares@ US$8.07Common StockSEC:0001140361-12-029114:0
- 8,930 shares@ US$2.74Common StockSEC:0001181431-12-030718:0Canonical exit: 13 Aug 2012 (T+90)
- 27,700 shares@ US$2.74Common StockSEC:0001181431-12-030718:1Canonical exit: 14 Aug 2012 (T+90)
- 34,200 shares@ US$2.48Common StockSEC:0001209191-11-058045:0Canonical exit: 20 Feb 2012 (T+90)
- 6,100 shares@ US$2.48Common StockSEC:0001209191-11-058045:1Canonical exit: 21 Feb 2012 (T+90)
- 8,696 shares@ US$6.90Common StockSEC:0001140361-11-030922:0
- 1,000 shares@ US$10.60Common StockSEC:0001140361-10-046565:0Canonical exit: 16 Feb 2011 (T+90)
- 7,585 shares@ US$7.91Common StockSEC:0001140361-10-024495:0
- 1,000 shares@ US$5.21Common StockSEC:0001140361-09-018740:0Canonical exit: 9 Nov 2009 (T+90)
- 1,000 shares@ US$32.50Common StockSEC:0001416041-09-000002:0Canonical exit: 5 Aug 2009 (T+90)
16 of 16 declarations
